Diabetes, Vol 39, Issue 12 1519-1526, Copyright © 1990 by American Diabetes Association
Application of chronic intravascular blood glucose sensor in dogs
JC Armour, JY Lucisano, BD McKean and DA Gough
Department of Applied Mechanics and Engineering Sciences, University of California, San Diego, La Jolla 92093.
An intravenous glucose sensor was implanted in six dogs for 1-15 wk. The
glucose sensor is a flexible cylinder, approximately 0.2 cm diam and 30 cm
long, with a tip containing immobilized glucose oxidase and catalase
coupled to a potentiostatic O2 sensor. The sensor and a similar O2
reference sensor were implanted in the superior vena cava near the entrance
of the right atrium. The sensor response was conveyed externally either by
a telemetry system implanted nearby, surgically accessed leads, or
chronically maintained percutaneous leads. Summing over the six implants,
there was a total implantation period of 333 days during which glucose
sensors were functional on demand. The sensor response showed agreement
with conventionally assayed blood samples after accounting for a response
lag. Sensor response to glucose showed little change over the implant
period. Biocompatibility, enzyme lifetime, O2 availability, O2 sensor
stability, and biochemical interference were not limitations. Results
demonstrated that this sensor can function effectively as an implant in
dogs for a period of months and has the potential for long-term operation.